New Diagnostics System Advances Cervical Cancer Screening
A breakthrough in technology, combining advanced artificial intelligence (AI) and diagnostics, will soon lead the way for advances in cervical cancer screening.
The new tech comes from Hologic, Inc. – an innovative medical tech company focused on improving women’s health through early detection and treatment of cancer.
Dubbed the Genius™ Digital Diagnostics System, it is a first-of-its-kind digital cytology platform. Using a new advanced AI algorithm to help analyze its digital imaging results, the system aids doctors in the identification of pre-cancerous lesions and cancer cells in women.
“Application of AI requires digital images that are of exceptional quality,” said Kevin Thornal, president, Diagnostic Solutions Division at Hologic.
“Our teams developed a breakthrough imaging technology that converts physical glass cytology slides into digital images with superior clarity. From this digitalization, advanced image analysis and improved standardization are now achievable.”
According to Hologic, the AI in the system is able to narrow down the field of thousands of cells in a Pap test slide to a handful of the most diagnostically relevant images.
This saves time for results analysis and will lead to earlier detection of anomalies. The end result is getting help to the patients sooner and with greater accuracy.